| For: | Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210 [PMID: 28694660 DOI: 10.3748/wjg.v23.i23.4200] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i23/4200.htm |
| Number | Citing Articles |
| 1 |
Shaimaa S. Ibrahim. Nanostructured Lipid Carriers for Oral Delivery of a Corticosteroid: Role of Formulation on Biopharmaceutical Performance. Journal of Pharmaceutical Sciences 2023; 112(3) doi: 10.1016/j.xphs.2022.10.014
|
| 2 |
Rania A. Abdel-Emam, Marwa F. Ali, Abeer S. Hassan, Rasha B. Abd-Ellatief. Development and evaluation of dexamethasone-loaded bioadhesive polymeric nanocapsules for mitigating cardiac and gastric adverse effects of free dexamethasone. Journal of Pharmaceutical Investigation 2024; 54(6) doi: 10.1007/s40005-024-00686-7
|
| 3 |
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann, Nazila Kamaly. Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 2022; doi: 10.1016/j.smim.2022.101664
|
| 4 |
Firoz Anwar, Salma Naqvi, Saiba Shams, Ryan Adnan Sheikh, Fahad A. Al-Abbasi, Amer H. Asseri, Mirza Rafi Baig, Vikas Kumar. Nanomedicines: intervention in inflammatory pathways of cancer. Inflammopharmacology 2023; 31(3) doi: 10.1007/s10787-023-01217-w
|
| 5 |
Dong Yan, Shuyu Ye, Yue He, Sidan Wang, Yi Xiao, Xin Xiang, Minzi Deng, Weiwei Luo, Xuejie Chen, Xiaoyan Wang. Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1286667
|
| 6 |
Wardah Khalid, Kifayat Ullah Shah, Muhammad Danish Saeed, Asif Nawaz, Fazal Ur Rehman, Muhammad Shoaib, Maqsood Ur Rehman, Abdullah F. Alasmari, Metab Alharbi, Fawaz Alasmari. 5-Fluorouracil-Loaded Hyaluronic Acid-Coated Niosomal Vesicles: Fabrication and Ex Vivo Evaluation for Skin Drug Delivery. ACS Omega 2023; 8(48) doi: 10.1021/acsomega.3c04457
|
| 7 |
Chi-Pin James Wang, Min Ji Byun, Se-Na Kim, Wooram Park, Hee Ho Park, Tae-Hyung Kim, Jung Seung Lee, Chun Gwon Park. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022; 345 doi: 10.1016/j.jconrel.2022.02.028
|
| 8 |
Gurpreet Kaur, Snimmer Kaur, Ashif KTK, Jaspreet Kaur. Green Sustainable Process for Chemical and Environmental Engineering and Science. 2023; doi: 10.1016/B978-0-323-95171-5.00011-X
|
| 9 |
Haichen Wang, Feifei Zhou, Mengdan Shen, Ronglin Ma, Qiang Yu. Classification of Nanomaterial Drug Delivery Systems for Inflammatory Bowel Disease. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S502546
|
| 10 |
Teresa D’Amore, Cinzia Zolfanelli, Vincenzo Lauciello, Alessio Di Ciancia, Alessio Vagliasindi, Slim Smaoui, Theodoros Varzakas. Using Postbiotics from Functional Foods for Managing Colorectal Cancer: Mechanisms, Sources, Therapeutic Potential, and Clinical Perspectives. Microorganisms 2025; 13(6) doi: 10.3390/microorganisms13061335
|
| 11 |
Murtada A. Oshi, Adnan Haider, Muhammad Irfan Siddique, Alam Zeb, Syed Babar Jamal, Atif Ali Khan Khalil, Muhammad Naeem. Nanomaterials for chronic inflammatory diseases: the current status and future prospects. Applied Nanoscience 2022; 12(11) doi: 10.1007/s13204-021-02019-8
|
| 12 |
Romain Brusini, Mariana Varna, Patrick Couvreur. Advanced nanomedicines for the treatment of inflammatory diseases. Advanced Drug Delivery Reviews 2020; 157 doi: 10.1016/j.addr.2020.07.010
|
| 13 |
Mei Yang, Yujie Zhang, Yana Ma, Xiangji Yan, Liuyun Gong, Mingzhen Zhang, Baojun Zhang. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020; 3(04) doi: 10.1097/JBR.0000000000000078
|
| 14 |
Kristina Lechner, Mahira Zeeshan, Maxi Noack, Hussain Ali, Markus F. Neurath, Benno Weigmann. Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD?. Expert Opinion on Drug Delivery 2022; 19(3) doi: 10.1080/17425247.2022.2043847
|
| 15 |
Chirag Patel, Sonal Pande, Ketan Ranch, Shery Jacob, Moawia M. Al-Tabakha, Sai H.S. Boddu. Nanocarriers Based Colon Targeting. 2025; doi: 10.1016/B978-0-443-24806-1.00008-X
|
| 16 |
Zhina Majdzadeh Ardekani, Ana L Lorenzo-Leal, Horacio Bach. Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review. Nanomedicine 2024; 19(2) doi: 10.2217/nnm-2023-0267
|
| 17 |
Muhammad Ahsan Waqar, Faryal Fatima, Muhammad Nabeel Rehman, Maha Khalid, Asma Ashraf, Jaweria Babar, Khadeeja Saqib, Maria Saleem. A comprehensive review on solid lipid nanoparticles as a new frontier for treatment of migraine. International Journal of Polymeric Materials and Polymeric Biomaterials 2026; 75(9) doi: 10.1080/00914037.2026.2626712
|
| 18 |
Giuseppe Cappellano, Cristoforo Comi, Annalisa Chiocchetti, Umberto Dianzani. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease. International Journal of Molecular Sciences 2019; 20(1) doi: 10.3390/ijms20010204
|
| 19 |
|
| 20 |
Melaine Maiara da Silva Lopes, Luísa Degrandi Sehn, Rafaela Zimmermann, Helder Ferreira Teixeira, Ursula Matte, Roselena Silvestri Schuh, Flávia Nathiely Silveira Fachel. An overview of the potentialities and recent advances in nanotechnology-based systems for glucocorticoids delivery. Journal of Drug Delivery Science and Technology 2026; 115 doi: 10.1016/j.jddst.2025.107659
|
| 21 |
Manoj Madanahalli Ramesh, Richard Lobo, Annegowda Hardur Venkatappa. Pharmacological enhancement of anti-inflammatory drug efficacy through solid lipid nanoparticles in osteoarthritis and rheumatoid arthritis: a review. Inflammopharmacology 2026; 34(4) doi: 10.1007/s10787-026-02205-6
|
| 22 |
Mohamed H. Desoqi, Hossam S. El-Sawy, Elsayed Kafagy, Mamdouh Ghorab, Shadeed Gad. Fluticasone propionate–loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats. Journal of Microencapsulation 2021; 38(3) doi: 10.1080/02652048.2021.1887383
|
| 23 |
Abdul Shakur Khan, Kifayat Ullah Shah, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Maitham A. Al Hawaj, Yousef N. Alhashem, Shakira Ghazanfar, Kamran Ahmad Khan, Zahid Rasul Niazi, Arshad Farid. Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications. Gels 2022; 8(2) doi: 10.3390/gels8020129
|
| 24 |
Fengqian Chen, Qi Liu, Yang Xiong, Li Xu. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. International Journal of Nanomedicine 2021; doi: 10.2147/IJN.S310952
|
| 25 |
Kelly Van Looveren, Charlotte Wallaeys, Claude Libert. Potential of glucocorticoids to treat intestinal inflammation during sepsis. Current Opinion in Pharmacology 2020; 53 doi: 10.1016/j.coph.2019.12.005
|
| 26 |
Rahul Mittal, Amit P. Patel, Vasanti M. Jhaveri, Sae-In S. Kay, Luca H. Debs, James M. Parrish, Debbie R. Pan, Desiree Nguyen, Jeenu Mittal, Rahul Dev Jayant. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opinion on Drug Delivery 2018; 15(3) doi: 10.1080/17425247.2018.1420055
|
| 27 |
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12) doi: 10.1093/ibd/izz205
|
| 28 |
D Raju. Case studies of enhanced pharmacodynamic activity of poorly oral bioavailable drugs via solid lipid nanoparticles. Journal of Drug Delivery and Therapeutics 2021; 11(2) doi: 10.22270/jddt.v11i2.4582
|
| 29 |
Lindsey M. Williams, Shijie Cao. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches. Pharmacology & Therapeutics 2024; 256 doi: 10.1016/j.pharmthera.2024.108605
|
| 30 |
Aoibhín Ryan, Pratikkumar Patel, Paula M. O’Connor, R. Paul Ross, Colin Hill, Sarah P. Hudson. Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147. Drug Delivery and Translational Research 2021; 11(4) doi: 10.1007/s13346-021-00984-9
|
| 31 |
Songwei Huang, Cheng Zhou, Bensong Wang, Jinlei Jiang, Ang Gao, Jiawei Peng, Ning Tang, Shengsheng Cui, Daxiang Cui. Recent advances in oral drug delivery materials for targeted diagnosis or treatment of gastrointestinal diseases. Journal of Drug Delivery Science and Technology 2023; 88 doi: 10.1016/j.jddst.2023.104903
|
| 32 |
Nitin Verma, Neha Kanojia, Vivek Puri, Ameya Sharma, Komal Thapa, Lata Rani, Mahesh Gupta, Dinesh Kumar Chellappan, Kamal Dua. Recent Developments in Anti-Inflammatory Therapy. 2023; doi: 10.1016/B978-0-323-99988-5.00020-6
|
| 33 |
Nidhi Mishra, Samipta Singh, Priyanka Maurya, Raquibun Nisha, Shubhini A. Saraf. Nanoformulations in Human Health. 2020; doi: 10.1007/978-3-030-41858-8_7
|
| 34 |
Tania Limongi, Francesca Susa, Marco Allione, Enzo di Fabrizio. Drug Delivery Applications of Three-Dimensional Printed (3DP) Mesoporous Scaffolds. Pharmaceutics 2020; 12(9) doi: 10.3390/pharmaceutics12090851
|
| 35 |
Prasad Minakshi, Rajesh Kumar, Mayukh Ghosh, Basanti Brar, Manju Barnela, Preeti Lakhani. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Current Topics in Medicinal Chemistry 2020; 20(11) doi: 10.2174/1568026620666200320113322
|
| 36 |
Ambreen Leghari, Faiz Muhammad Khand, Sheereen Laghari, Shakeel Ahmed Lakho. Engineering bioavailability: Polysaccharide-protein-lipid delivery platforms for postbiotic therapeutics in gastrointestinal and systemic disorders. International Journal of Biological Macromolecules 2026; 351 doi: 10.1016/j.ijbiomac.2026.151123
|
| 37 |
Manu Sharma, Shipra Sharma, Jyoti Wadhwa.
Improved uptake and therapeutic intervention of curcumin
via
designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1) doi: 10.1080/21691401.2018.1543191
|
| 38 |
Fransisca Leonard, Srimeenakshi Srinivasan, Xuewu Liu, Eva-Maria Collnot, Mauro Ferrari, Claus-Michael Lehr, Biana Godin. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 2020; 151 doi: 10.1016/j.ejpb.2020.03.020
|
| 39 |
Aoibhín Ryan, Pratikkumar Patel, Paula M. O'Connor, Jennifer Cookman, R. Paul Ross, Colin Hill, Sarah P. Hudson. Single versus double occupancy solid lipid nanoparticles for delivery of the dual-acting bacteriocin, lacticin 3147. European Journal of Pharmaceutics and Biopharmaceutics 2022; 176 doi: 10.1016/j.ejpb.2022.05.016
|
| 40 |
Yu Zheng, Yuke Li, Mao Li, Rujing Wang, Yuhong Jiang, Mengnan Zhao, Jun Lu, Rui Li, Xiaofang Li, Sanjun Shi. COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms. Medicinal Research Reviews 2024; 44(2) doi: 10.1002/med.21997
|
| 41 |
Siyu Zhu, Zhenlin Yang, Yulong Liu, Lan Cheng, Dingpei Long, Fangyin Dai. Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects. Pharmaceutics 2025; 17(5) doi: 10.3390/pharmaceutics17050547
|
| 42 |
De-feng Li, Mei-feng Yang, Hao-ming Xu, Min-zheng Zhu, Yuan Zhang, Cheng-mei Tian, Yu-qiang Nie, Jian-yao Wang, Yu-jie Liang, Jun Yao, Li-sheng Wang. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. Journal of Materials Chemistry B 2022; 10(31) doi: 10.1039/D2TB01190E
|
| 43 |
Mengqing Hu, Yimiao Zhou, Lin Yang, Liquan Zhou, Xiao Liu, Tianjin Ma, Zuowei Xiao. Advances in Nano-Drug Delivery Systems for Chronic Autoimmune Diseases: A Focus on Diabetes Mellitus, Inflammatory Bowel Disease, and Rheumatoid Arthritis. Molecules 2026; 31(12) doi: 10.3390/molecules31122094
|
| 44 |
Maria J Barahona, Vanessa Baratta, Jenna Ollodart, David Mulligan, John P Geibel. Design and Implementation of Novel Nutraceuticals and Derivatives for Treating Intestinal Disorders. Future Medicinal Chemistry 2019; 11(8) doi: 10.4155/fmc-2018-0313
|
| 45 |
Arun Karnwal, Amar Jassim, Ameer Mohammed, Vikas Sharma, Abdel Al-Tawaha, Iyyakkannu Sivanesan. RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine. Pharmaceuticals 2024; 17(12) doi: 10.3390/ph17121711
|
| 46 |
Esther Prieto, Maria Jose Cardiel, Eugenio Vispe, Miriam Idoipe, Elena Garcia-Martin, Jose Maria Fraile, Vicente Polo, Jose Antonio Mayoral, Luis Emilio Pablo, Maria Jesus Rodrigo. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation. Biomedical Materials 2020; 15(6) doi: 10.1088/1748-605X/aba445
|
| 47 |
Vijay Sagar Madamsetty, Reza Mohammadinejad, Ilona Uzieliene, Noushin Nabavi, Ali Dehshahri, Jomarien García-Couce, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, Pooyan Makvandi, Abbas Pardakhty, Abbas Aghaei Afshar, Ali Seyfoddin. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomaterials Science & Engineering 2022; 8(5) doi: 10.1021/acsbiomaterials.2c00026
|
| 48 |
Alba Pensado-López, Aldo Ummarino, Sophia Khan, Anna Guildford, Iain U. Allan, Matteo Santin, Nathalie Chevallier, Elina Varaillon, Elizaveta Kon, Paola Allavena, Fernando Torres Andón. Synthetic peptides of IL-1Ra and HSP70 have anti-inflammatory activity on human primary monocytes and macrophages: Potential treatments for inflammatory diseases. Nanomedicine: Nanotechnology, Biology and Medicine 2024; 55 doi: 10.1016/j.nano.2023.102719
|
| 49 |
Wenyuan Xu, Qiulin Deng, Liuhong Chen, Xishun Zhou, Yao Dong, Chenran Ren, Xi Zeng, Deliang Cao. Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges. Nanomedicine: Nanotechnology, Biology and Medicine 2026; 71 doi: 10.1016/j.nano.2025.102894
|
| 50 |
Shangjun Fu, Zongyun He, Yongfeng Tang, Bo Lan. Effect of Mn3O4 Nanoparticles on Lipopolysaccharide-Induced Inflammatory Factors in the Human Tendon Cells and Its Mechanism. International Journal of Polymer Science 2020; 2020 doi: 10.1155/2020/1934732
|
| 51 |
Sakshi Aggarwal, Prakash Haloi, Muskan Kumari Agarwal, Priyanka Saroj, Navneet Sharma, Pratap Kalita. Advances in inflammatory bowel disease (IBD): Immune mechanisms, preclinical models, and emerging therapeutic strategies. Journal of Drug Delivery Science and Technology 2026; 122 doi: 10.1016/j.jddst.2026.108420
|
| 52 |
Hai‑Lian Du, Ai‑Dong Zhai, Hong Yu. Synergistic effect of halofuginone and dexamethasone on LPS‑induced acute lung injury in type II alveolar epithelial cells and a rat model. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10865
|
| 53 |
Advancement of nanomedicines in chronic inflammatory disorders. Inflammopharmacology 2022; 30(2) doi: 10.1007/s10787-022-00927-x
|
| 54 |
Chinmay M. Jogdeo, Sudipta Panja, Shrey Kanvinde, Ekta Kapoor, Kasturi Siddhanta, David Oupický. Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases. Advanced Healthcare Materials 2023; 12(7) doi: 10.1002/adhm.202202400
|
| 55 |
Dongdong Liu, Meng Wei, Wenrui Yan, Hua Xie, Yingbao Sun, Bochuan Yuan, Yiguang Jin. Potential applications of drug delivery technologies against radiation enteritis. Expert Opinion on Drug Delivery 2023; 20(4) doi: 10.1080/17425247.2023.2183948
|
| 56 |
Andreia S. Barros, Rute Nunes, Bruno Sarmento. Targeted therapeutics for IBD unraveling the potential of stimulus-responsive nanoparticles. Journal of Controlled Release 2026; 389 doi: 10.1016/j.jconrel.2025.114466
|
| 57 |
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Mohd Yasir, Omar Awad Alsaidan, Ali Alquraini, Alenazy Rawaf, Bader Alsuwayt, Md. Khalid Anwer, Sultan Alshehri, Mohammed M. Ghoneim. Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation. Pharmaceutics 2022; 14(3) doi: 10.3390/pharmaceutics14030507
|
| 58 |
Yu Jeong Kim, Nayoon Park, Xiaoliang Cheng, Yonghyun Lee. Advanced engineering of microbiome-related therapeutics for targeted treatment of inflammatory bowel diseases. Journal of Controlled Release 2026; 394 doi: 10.1016/j.jconrel.2026.114872
|
| 59 |
Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of Pharmacal Research 2020; 43(1) doi: 10.1007/s12272-020-01219-0
|
| 60 |
Bapi Gorain, Sreenivas Patro Sisinthy, Hira Choudhury, Prashant Kesharwani. Theory and Applications of Nonparenteral Nanomedicines. 2021; doi: 10.1016/B978-0-12-820466-5.00010-7
|
| 61 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1563805
|
| 62 |
Omprakash Sunnap, Singaravadivel Subramanian, Praveen Kumar Vemula, Sekar Karuppannan. Zingerone‐encapsulated Solid Lipid Nanoparticles as Oral Drug‐delivery Systems to Potentially Target Inflammatory Diseases. ChemNanoMat 2022; 8(12) doi: 10.1002/cnma.202200388
|
| 63 |
Syed Benazir Alam, Zhimin Yan, Nishita Hiresha Verma, Larry D. Unsworth, Marianna Kulka. Butyrate Increases Heparin Synthesis and Storage in Human Mast Cells. Cells 2024; 13(15) doi: 10.3390/cells13151241
|
| 64 |
Ahmed A. Katamesh, Khaled Almansour, Shimaa M. Hassoun, Ossama M. Sayed, Mohammed Khaled Bin Break, Randa Mohammed Zaki, Obaid Afzal, Amr Radwan. Inflammatory lung diseases: a clinical and scientific review of the latest advances and challenges. Pharmacological Reports 2025; 77(4) doi: 10.1007/s43440-025-00749-y
|
| 65 |
Mayukh Jana, Ujjwal Kumar Biswas, Chandra Sekhar Patro, Biplab Debnath, Suraj Sharma, Sweet Naskar. Solid Lipid Nanoparticles: A Review of their Biomedical Applications and Preparation. Pharmaceutical Nanotechnology 2025; 13(4) doi: 10.2174/0122117385312175240502100018
|
| 66 |
Farhan Mazahir. Precision nanomedicines in glioblastoma therapy and challenges remain. Next Nanotechnology 2026; 9 doi: 10.1016/j.nxnano.2026.100431
|